
Twist Bioscience: A leading US biotech firm specializing in synthetic DNA for diverse applications.
Twist Bioscience, founded in 2013, is a biotechnology company dedicated to advancing synthetic DNA technology. Its core mission is to drive biological innovations that make the world safer, healthier, and more sustainable. The company offers a range of DNA-based tools and services, including gene synthesis, DNA libraries, and data storage solutions. Twist Bioscience focuses on various markets such as drug discovery, cancer research, human genetics, agricultural biotechnology, animal health, and infectious disease research.
Notable figures associated with Twist Bioscience include co-founder and CEO Emily Leproust. The company has attracted significant investment from prominent venture capital firms and has achieved key milestones such as developing high-throughput DNA synthesis platforms. Twist Bioscience's impact is evident in its contributions to groundbreaking scientific research and its role in enabling advancements across multiple disciplines.

Switchback Systems
switchbacksys.com

Ansa Biotechnologies
ansabio.com

Synthego
synthego.com

Ginkgo Bioworks
ginkgobioworks.com

TwinStrand Biosciences
twinstrandbio.com

Synthex

Mammoth Biosciences

Molecular Assemblies

10x Genomics
10xgenomics.com

Element Biosciences

Fluidigm
standardbio.com

Absci
absci.com

Bluestem Biosciences

Think Bioscience

Synlife
synlifebio.com
Companies similar to Twist Bioscience include Switchback Systems, Ansa Biotechnologies, Synthego and Ginkgo Bioworks.
Twist Bioscience was founded in 2013.
Twist Bioscience's headquarters is located in San Francisco, CA, US.
Twist Bioscience's most recent funding round was for $250M (USD) in February 2022.
As of Feb 10, 2022, Twist Bioscience has raised a total of $553.1M (USD).
Twist Bioscience has 989 employees as of Feb 6, 2024.